These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6531789)

  • 1. Infiltration of liver and brain by tumor cells in leukemic mice: prevention by dimethyltriazenes and cyclophosphamide.
    Sava G; Giraldi T; Perissin L; Zorzet S; Mallardi F; Grill V
    Tumori; 1984 Dec; 70(6):477-83. PubMed ID: 6531789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimetastatic action and hematological toxicity of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt and 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide used as prophylactic adjuvants to surgical tumor removal in mice bearing B16 melanoma.
    Sava G; Giraldi T; Lassiani L; Nisi C
    Cancer Res; 1984 Jan; 44(1):64-8. PubMed ID: 6690062
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the antitumor activity of DTIC and 1-p-(3,3-dimethyl-1-triazeno) benzoic acid potassium salt on murine transplantable tumors and their hematological toxicity.
    Colombo T; D'Incalci M
    Cancer Chemother Pharmacol; 1984; 13(2):139-41. PubMed ID: 6467499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of antimetastatic dimethyltriazenes in mice bearing Lewis lung carcinoma lines with different metastatic potential.
    Sava G; Giraldi T; Zupi G; Sacchi A
    Invasion Metastasis; 1984; 4(3):171-8. PubMed ID: 6480289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antimetastatic, antiinvasive and cytotoxic agents on the growth and spread of transplantable leukemias in mice.
    Sava G; Giraldi T; Perissin L; Zorzet S; Decorti G
    Clin Exp Metastasis; 1987; 5(1):27-34. PubMed ID: 2951046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dimethyltriazenes on in vitro Lewis lung carcinoma tumor lines with different metastatic capacity.
    Zupi G; Corsi A; Sacchi A; Lassiani L; Giraldi T
    Invasion Metastasis; 1984; 4(3):179-88. PubMed ID: 6480290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity of the antimetastatic and cytotoxic effects of 1-p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt (+/-)-1,2-di(3,5-dioxopiperazin-1-yl)propane, and cyclophosphamide in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Cuman R; Nisi C; Lassiani L
    Cancer Res; 1981 Jun; 41(6):2524-8. PubMed ID: 7237446
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt on leukemic infiltration of brain and liver in mice bearing P388 leukemia.
    Sava G; Giraldi T; Bartoli-Klugmann F; Decorti G; Mallardi F
    Eur J Cancer Clin Oncol; 1984 Feb; 20(2):287-9. PubMed ID: 6538492
    [No Abstract]   [Full Text] [Related]  

  • 9. Mutagenic activity of the dacarbazine analog p-(3,3-dimethyl-1-triazeno)benzoic acid potassium salt in bacterial cells.
    Tamaro M; Dolzani L; Monti-Bragadin C; Sava G
    Pharmacol Res Commun; 1986 May; 18(5):491-501. PubMed ID: 3526359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK.
    Sava G; Zorzet S; Perissin L; Pacor S; Lassiani L; Nisi C; Varnavas A
    Cancer Chemother Pharmacol; 1991; 27(6):423-8. PubMed ID: 2013112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1-Aryl-3,3-dimethyltriazenes: potential central nervous system active analogues of 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC).
    Farquhar D; Benvenuto J
    J Med Chem; 1984 Dec; 27(12):1723-7. PubMed ID: 6502603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostasis and mechanism of action of selective antimetastatic drugs in mice bearing Lewis lung carcinoma.
    Giraldi T; Sava G; Mitri E; Cherubino R
    Eur J Cancer Clin Oncol; 1984 Jul; 20(7):961-6. PubMed ID: 6540195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe myelosuppression from piperazinedione, (NSC No. 135758), cyclophosphamide plus dimethyl-triazeno-imidazole carboxamide (DTIC).
    Presant CA; Klahr C
    Cancer; 1977 Oct; 40(4):1386-9. PubMed ID: 907959
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-mediated increase of tumor immunogenicity in vivo for a new approach to experimental cancer immunotherapy.
    Giampietri A; Bonmassar A; Puccetti P; Circolo A; Goldin A; Bonmassar E
    Cancer Res; 1981 Feb; 41(2):681-7. PubMed ID: 7448813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activity and inhibition by cytotoxic and antimetastatic drugs of cathepsin B-like cysteine proteinase in transplantable leukemias in mice.
    Giraldi T; Sava G; Zorzet S; Perissin L; Piccini P
    Anticancer Res; 1987; 7(3 Pt B):343-6. PubMed ID: 3307599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy and immunotherapy of L1210 leukemic mice with antigenic tumor sublines.
    Nicolin A; Canti G; Marelli O; Veronese F; Goldin A
    Cancer Res; 1981 Apr; 41(4):1358-62. PubMed ID: 7011535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic antimetastatic treatment with aryldimethyltriazenes as adjuvants to surgical tumor removal in mice bearing Lewis lung carcinoma.
    Sava G; Giraldi T; Nisi C; Bertoli G
    Cancer Treat Rep; 1982 Jan; 66(1):115-20. PubMed ID: 7053247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism and mechanism of the antileukemic action of isomeric aryldimethyltriazenes.
    Sava G; Giraldi T; Lassiani L; Nisi C
    Cancer Treat Rep; 1982 Sep; 66(9):1751-5. PubMed ID: 7116350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical trial of procarbazine plus vincristine plus bis-chloroethyl-nitrosourea plus imidazole carboxamide dimethyl triazeno in metastatic malignant melanoma.
    Van Dyk JJ; Falkson G
    Med Pediatr Oncol; 1975; 1(2):107-11. PubMed ID: 1228411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of DTIC (NSC-45388) in animals.
    Venditti JM
    Cancer Treat Rep; 1976 Feb; 60(2):135-40. PubMed ID: 1260771
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.